Atai Life Sciences N.V.
biopharmaceutical company aiming to transform the treatment of mental health disorders
🤖
AI Overview
With $165K in lobbying spend across 7 quarterly filings, Atai Life Sciences N.V is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.
$165K
Total Spend
2
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $115K |
| 2022 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
- •DEA Restrictions on Psychedelics
- •Coverage and Reimbursement for Mental Health Services
- •Company Drug Development Updates
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Walgreen Company
$24.4M total spend
Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions
$22.7M total spend
Advocate Aurora Health, INC.
$16.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.